Page last updated: 2024-10-22

aminoglutethimide and Cystic Fibrosis

aminoglutethimide has been researched along with Cystic Fibrosis in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grubb, BR1
Boucher, RC1

Other Studies

1 other study available for aminoglutethimide and Cystic Fibrosis

ArticleYear
Effect of in vivo corticosteroids on Na+ transport across airway epithelia.
    The American journal of physiology, 1998, Volume: 275, Issue:1

    Topics: Adrenal Cortex Hormones; Adrenalectomy; Aldosterone; Aminoglutethimide; Animals; Biological Transpor

1998